The Lancet, 0140-6736

Journal

1 - 10 out of 439Page size: 10

Publications

  1. 2020
  2. Published

    Quality of primary health care in China: challenges and recommendations

    KK Cheng & 12 others, , 6 Jun 2020, In : The Lancet. 395, 10239, p. 1802-1812 11 p.

    Research output: Contribution to journal › Review article

  3. E-pub ahead of print

    Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

    29 May 2020, In : The Lancet.

    Research output: Contribution to journal › Article

  4. Published

    Use of emergency ambulance services for heart attack and stroke over the COVID-19 lockdown

    Richard Lilford, 23 May 2020, In : The Lancet. 395, 10237, p. e93-e94 2 p.

    Research output: Contribution to journal › Article

  5. E-pub ahead of print

    Who is most likely to be infected with SARS-CoV-2?

    Rachel Jordan & Peymane Adab, 15 May 2020, In : The Lancet. 2 p.

    Research output: Contribution to journal › Comment/debate

  6. E-pub ahead of print

    Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

    Rik Bryan & 4 others, , 5 Mar 2020, In : The Lancet. p. 1-10 10 p.

    Research output: Contribution to journal › Article

  7. Published

    Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCSS): a multicentre, randomised controlled trial

    Aneel Bhangu, Natalie Rowland, Laura Magill, James Glasbey, Kelly Handley, Samir Mehta, Dion Morton, Thomas Pinkney & Andrew Beggs, 8 Feb 2020, In : The Lancet. 395, 10222, p. 417-426

    Research output: Contribution to journal › Article

  8. Accepted/In press

    Effectiveness of the Arabin cervical pessary to prevent preterm birth in women with a twin pregnancy and short cervix: open randomised trial and updated meta-analysis

    Mark Kilby, 21 Jan 2020, (Accepted/In press) In : The Lancet.

    Research output: Contribution to journal › Article

  9. 2019
  10. Published

    Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

    Sudha Sundar & 9 others, , 7 Dec 2019, In : The Lancet. 394, 10214, p. 2084-2095 12 p.

    Research output: Contribution to journal › Article

  11. Published

    The 2019 Report of the Lancet Countdown on Health and Climate Change: Ensuring the Health of a Child Born Today is Not Defined by a Changing Climate

    Niheer Dasandi, 16 Nov 2019, In : The Lancet. 394, 10211, p. 1836 1878 p.

    Research output: Contribution to journal › Article

  12. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial

    9 Nov 2019, In : The Lancet. 394, 10210, p. 1713-1723 11 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...44 Next